Acorda Therapeutics Inc EBITDA margin
What is the EBITDA margin of Acorda Therapeutics Inc?
The EBITDA margin of Acorda Therapeutics Inc is -3.45%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Health Care sector on NASDAQ compared to Acorda Therapeutics Inc
What does Acorda Therapeutics Inc do?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Companies with ebitda margin similar to Acorda Therapeutics Inc
- Gold By Gold SA has EBITDA margin of -3.47%
- Dominate has EBITDA margin of -3.47%
- China Natural Resources Inc has EBITDA margin of -3.46%
- Fe has EBITDA margin of -3.46%
- I.T has EBITDA margin of -3.46%
- Hermitage Offshore Services has EBITDA margin of -3.46%
- Acorda Therapeutics Inc has EBITDA margin of -3.45%
- Zinc Media plc has EBITDA margin of -3.43%
- China Shun Ke Long has EBITDA margin of -3.43%
- Umang Dairies has EBITDA margin of -3.42%
- China Jo-Jo Drugstores Inc has EBITDA margin of -3.42%
- GE T&D India has EBITDA margin of -3.40%
- Kirkland`s Inc has EBITDA margin of -3.40%